Navigantis
Empowering physicians to deliver uncompromised neurovascular care by creating the new frontier in surgical robotics.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | $12.0m | Series A | |
| Total Funding | 000k | ||
Navigantis is a medical robotics company that has developed the Vasco interventional robotic platform, a technology designed for a wide range of neurovascular procedures, including the treatment of acute ischemic stroke. The company was founded in 2022 and has a presence in both Miami, Florida, and Seoul, South Korea.
Navigantis has secured $12 million in funding to advance the development of its robotic platform. The company's technology is aimed at empowering physicians to deliver uncompromised neurovascular care by creating a new frontier in surgical robotics. The Vasco platform has already been used to successfully complete a first-in-human neurovascular procedure.
Keywords: medical robotics, neurovascular, interventional platform, surgical robotics, ischemic stroke, medical devices, healthcare technology, robotics, neurosurgery, endovascular